Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2022-05-26
2025-02-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Related Quality of Life Effects of Off-the-shelf Computer Gaming in Alzheimer and Related Disorders Populations
NCT01416012
Training to Enhance Cognition in Older Adults
NCT03900702
Impact of Combined Behavioral Interventions on Cognitive Outcomes in MCI
NCT02864069
Dual-Task Exercise for Mild Traumatic Brain Injury (mTBI)
NCT06037603
Efficacy of Computer-Based Cognitive Game Training for Healthy Elderly
NCT03940079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Walking regimen (W)
Walking (W)
Participants engage in 30 min of walking daily, for three weeks.
Walking regimen + gamified inhibitory control training (W+PolyRules!)
Walking + PolyRules! (W+PolyRules!)
Participants alternate between 30 min of walking on half of the days and 30 min of gamified inhibitory control on the other days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Walking (W)
Participants engage in 30 min of walking daily, for three weeks.
Walking + PolyRules! (W+PolyRules!)
Participants alternate between 30 min of walking on half of the days and 30 min of gamified inhibitory control on the other days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able and willing to walk independently with or without walking aids
* Able and willing to engage in 30 minutes of walking daily
* Able and willing to wear a fitness tracking device (e.g. Fitbit)
* Not currently engaging in a daily walking regimen of 30 minutes or more a day
Exclusion Criteria
* Undergoing active cancer treatment
* Diagnosis of peripheral neuropathy, severe musculoskeletal or neurodegenerative disease (e.g. dementia, multiple sclerosis, Parkinson's disease, Huntington's disease, etc.)
* Taking medications that may affect cognitive function
* Pacemaker, implantable cardiac defibrillator, neuro-stimulation devices, cochlear implants, implantable hearing aids, or other electronic medical equipment
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cedars-Sinai Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sarah Salvy
Professor, Department of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah J Salvy, PhD
Role: PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cedars-Sinai Medical Center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00001030
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.